Forte Biosciences, Inc. (FBRX)

Forte Biosciences Analyst Ratings

• Total Analysts: 1
• Consensus Rating: Strong Buy
• Price Target: $2.75
• Upside: +285.10%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Higgins Ladenburg Thalmann	Ladenburg Thalmann	Hold → Strong Buy Upgrades $2.75	Hold → Strong Buy	Upgrades	$2.75	+285.10%	Apr 8, 2024
Keay Nakae Chardan Capital	Chardan Capital	Strong Sell → Hold Upgrades n/a	Strong Sell → Hold	Upgrades	n/a	n/a	Sep 20, 2021
Kumaraguru Raja Brookline Capital	Brookline Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Sep 3, 2021
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy → Strong Sell Downgrades n/a	Strong Buy → Strong Sell	Downgrades	n/a	n/a	Sep 3, 2021
Michael Higgins Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Sep 3, 2021
Kalpit Patel B. Riley Securities	B. Riley Securities	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Sep 3, 2021
Nicole Germino Truist Securities	Truist Securities	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Sep 3, 2021
Mohit Bansal Citigroup	Citigroup	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Mar 26, 2021
Gbola Amusa Chardan Capital	Chardan Capital	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Mar 17, 2021
Gbola Amusa Chardan Capital	Chardan Capital	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Sep 24, 2020
Gbola Amusa Chardan Capital	Chardan Capital	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Sep 10, 2020
Raja Kumaraguru Brookline Capital	Brookline Capital	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Aug 28, 2020
Gbola Amusa Chardan Capital	Chardan Capital	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Aug 28, 2020